37 related articles for article (PubMed ID: 29681496)
21. Corrigendum to "An altered REDOX environment, assisted by over-expression of fetal hemoglobins, protects from inflammatory colitis and reduces inflammatory cytokine expression" [Int. Immunopharmacol. 50 (2017) 69-76].
Gorczynski RM; Alexander C; Brandenburg K; Chen Z; Heini A; Neumann D; Mach JP; Rietschel ET; Terskikh A; Ulmer AJ; Yu K; Zahringer U; Khatri I
Int Immunopharmacol; 2018 Jun; 59():414. PubMed ID: 29681495
[No Abstract] [Full Text] [Related]
22. Corrigendum to "Stereocalpin A inhibits the expression of adhesion molecules in activated vascular smooth muscle cells" [Int. Immunopharmacol. 12 (2012) 315-325].
Byeon HE; Park BK; Yim JH; Lee HK; Moon EY; Rhee DK; Pyo S
Int Immunopharmacol; 2019 Jan; 66():389. PubMed ID: 30503384
[No Abstract] [Full Text] [Related]
23. Corrigendum to "Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway" [Int. Immunopharmacol. 56 (2018) 65-70].
Yi L; Lyu YJ; Peng C; Zhu RL; Bai SS; Liu L; Wang PX; Zhou H; Dong Y
Int Immunopharmacol; 2018 Sep; 62():339. PubMed ID: 30007832
[No Abstract] [Full Text] [Related]
24. Corrigendum to "Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism". [Int. Immunopharmacol. 65 (2018) 256-267].
Wang D; Lao L; Pang X; Qiao Q; Pang L; Feng Z; Bai F; Sun X; Lin X; Wei J
Int Immunopharmacol; 2020 Jul; 84():106291. PubMed ID: 32094005
[No Abstract] [Full Text] [Related]
25. Corrigendum to "IDO1: An important immunotherapy target in cancer treatment" [Int. Immunopharmacol. 47 (2017) 70-77].
Li F; Zhang R; Li S; Liu J
Int Immunopharmacol; 2017 Aug; 49():231. PubMed ID: 28457914
[No Abstract] [Full Text] [Related]
26. Corrigendum to "Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis" [Int. Immunopharmacol. 57 (2018) 112-120].
Kos O; Alexander C; Brandenburg K; Chen Z; Heini A; Heumann D; Khatri I; Mach JP; Rietschel ET; Terskikh A; Ulmer AJ; Waelli T; Yu K; Zähringer U; Gorczynski RM
Int Immunopharmacol; 2018 Jun; 59():413. PubMed ID: 29681496
[No Abstract] [Full Text] [Related]
27. Role of intergenic human gamma-delta-globin sequences in human hemoglobin switching and reactivation of fetal hemoglobin in adult erythroid cells.
Bank A; O'Neill D; Lopez R; Pulte D; Ward M; Mantha S; Richardson C
Ann N Y Acad Sci; 2005; 1054():48-54. PubMed ID: 16339651
[TBL] [Abstract][Full Text] [Related]
28. [Biochemical markers of bone turnover. New aspect. Bone collagen metabolism: new biological markers for estimation of bone quality].
Saito M
Clin Calcium; 2009 Aug; 19(8):1110-7. PubMed ID: 19638694
[TBL] [Abstract][Full Text] [Related]
29. [Mesenchymal stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis].
Justesen J; Stenderup K; Kassem MS
Ugeskr Laeger; 2001 Oct; 163(40):5491-5. PubMed ID: 11601113
[TBL] [Abstract][Full Text] [Related]
30. A new concept of stem cell disorders and their new therapy.
Ikehara S
J Hematother Stem Cell Res; 2003 Dec; 12(6):643-53. PubMed ID: 14977474
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
